Results 1 to 10 of about 381,135 (230)
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease [PDF]
Pharmaceuticals, 2023 Unfractionated heparin has multiple pharmacological activities beyond anticoagulation. These anti-inflammatory, anti-microbial, and mucoactive activities are shared in part by low molecular weight and non-anticoagulant heparin derivatives.
Janis Kay Shute
doaj +3 more sources
Low molecular-weight heparin is better than warfarin for prevention of recurrent venous thromboembolism in cancer patients [PDF]
New England Journal of Medicine, 2017 A critical appraisal and clinical application of Lee AYY, Levin MN, Bake RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
Choi, Sarah
core +3 more sources
LOW MOLECULAR WEIGHT HEPARINS [PDF]
Medical Journal Armed Forces India, 1998 Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants. They represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948.
J N, Huang, A, Shimamura
openaire +4 more sources
Poly(dimethylsiloxane)-poly(ethyleneoxide)-heparin block copolymers. I. Synthesis and characterization [PDF]
, 1988 Amphiphilic block copolymers containing poly(dimethylsiloxane), poly(ethylene oxide), and heparin (PDMS-PEO-Hep) have been prepared via a series of coupling reactions using functionalized prepolymers, diisocyanates, and derivatized heparins.
Agarwal +40 more
core +21 more sources
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.
New England Journal of Medicine, 2023 BACKGROUND Clinical guidelines recommend low-molecular-weight heparin for thromboprophylaxis in patients with fractures, but trials of its effectiveness as compared with aspirin are lacking.
R. O’Toole +16 more
semanticscholar +1 more source
Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin [PDF]
Journal of the Serbian Chemical Society, 2009 The interaction between trypsin, a prototype S1 serine protease, with heparin and its low molecular weight derivative dalteparin were investigated. Direct inhibition of the proteolytic activity of trypsin by heparin and dalteparin, used in concentrations
OLIVERA M. BOSNIĆ +3 more
doaj +3 more sources
Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination [PDF]
, 2014 Rationale: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of ...
Hagmann, Henning +10 more
core +12 more sources
American Heart Journal Plus, 2023 Unfractionated heparin (UFH) is commonly used for several life-threatening conditions requiring anticoagulant therapy but failure to reach therapeutic levels in 24 h can be associated with adverse outcomes.
Kayla Torppey +7 more
doaj +1 more source
American Journal of Obstetrics and Gynecology, 2021 BACKGROUND Evidence on the impact of low-molecular-weight heparin, alone or in combination with low-dose aspirin, for the prevention for preeclampsia in high-risk patients is conflicting.
M. Cruz-Lemini +3 more
semanticscholar +1 more source